Talks
Secondary Hyperparathyroidism Issues
May 23, 2026
Calcium Homeostasis in CKD
May 23, 2026
Management of Hyperphosphatemia in CKD
May 23, 2026
Consequences of Hyperphosphatemia in CKD
May 23, 2026
Phosphate in CKD
May 23, 2026
Soluble Guanylate Cyclase Agonists
May 23, 2026
Aldosterone Synthase Inhibitors
May 23, 2026
Endothelin Receptor Antagonists (ERAs)
May 23, 2026
Pre-CKD
May 23, 2026
CKD Remission?
May 23, 2026
Hypoglycemia Severity
May 10, 2026
Hypoglycemia Severity
May 10, 2026
Insulin Titration: Persistent Hyperglycemia
May 10, 2026
Insulin Titration: Persistent Hyperglycemia
May 10, 2026
Insulin Titration: Pre-Prandial
May 10, 2026
Insulin Titration: Pre-Prandial
May 10, 2026
Initial Insulin Titration
May 10, 2026
Initial Insulin Titration
May 10, 2026
Initiating Insulin
May 10, 2026
Initiating Insulin
May 10, 2026
When to Consider Insulin
May 10, 2026
When to Consider Insulin
May 10, 2026
Causes of Hypoglycemia
May 10, 2026
Causes of Hypoglycemia
May 10, 2026
Persistent Hyperglycemia
May 10, 2026
Persistent Hyperglycemia
May 10, 2026
Oral Glucose Tolerance Test
May 2, 2026
Oral Glucose Tolerance Test
May 2, 2026
Euglycemic DKA
May 2, 2026
Euglycemic DKA
May 2, 2026
KDIGO 2024 Exercise Recommendations
April 2, 2026
KDIGO 2024 Blood Pressure Guideline
April 2, 2026
KDIGO 2024 Nutrition Recommendations
April 2, 2026
Finerenone in CKD and T2DM
April 2, 2026
FLOW Trial: Secondary Analysis
April 2, 2026
Microvascular Complications
April 1, 2026
FLOW Trial: GLP-1s and CKD
April 2, 2026
Microvascular Complications
April 1, 2026
Microvascular Screening
April 1, 2026
Risk Factors for CKD
April 1, 2026
Microvascular Screening
April 1, 2026
Diagnosis of Type 2 Diabetes
April 1, 2026
CKD Staging
April 1, 2026
Diagnosis of Type 2 Diabetes
April 1, 2026
Pathophysiology of T2DM
April 1, 2026
Pathophysiology of T2DM
April 1, 2026
GLP Receptor Agonist Therapy for T2DM
April 1, 2026
GLP Receptor Agonist Therapy for T2DM
April 1, 2026
SGLT2 Inhibitor Therapy for T2DM
April 1, 2026
SGLT2 Inhibitor Therapy for T2DM
April 1, 2026
Diagnosis of CKD
April 1, 2026
Metformin for T2DM
April 1, 2026
Metformin for T2DM
April 1, 2026
Epidemiology of Chronic Kidney Disease
April 1, 2026
Lifestyle Changes for T2DM
April 1, 2026
Lifestyle Changes for T2DM
April 1, 2026
Macrovascular Complications
April 1, 2026
Macrovascular Complications
April 1, 2026
HbA1c Targets
April 1, 2026
HbA1c Targets
April 1, 2026
Close button
Why are you reporting this TALK?